P. Brian Giles, Ph.D., J.D., has joined Meunier Carlin & Curfman, LLC as an associate attorney focused on patent prosecution, due diligence and patent strategy in the areas of biotechnology, pharmaceuticals and medical devices. Giles graduated magna cum laude from Georgia State University College of Law in 2011. He has a Ph.D. from the Medical University of South Carolina in Molecular and Cellular Biology and Pathobiology.
Giles has eight years of experience with other law firms as an associate, patent agent and scientific advisor. Giles has experience protecting a wide variety of biotechnologies, including stem cells, proteins, oligonucleotides, viral vectors, antibody technology, screening assays and tissue engineering. His experience includes preparing patent applications and invalidity, freedom to operate and non-infringement opinion letters, and prosecuting U.S. and foreign patent applications.
While at Georgia State College of Law, Giles was the Associate Editor of Georgia State Law Review. He also received CALI Excellence for the Future Awards in Advanced Legal Writing, Corporations, Copyrights, Georgia Practice and Procedure, Intellectual Property, Criminal Law, Research, Writing and Advocacy, Security Interest and Liens.
As part of his dissertation research, Giles evaluated the role of Vascular Endothelial Growth Factor (VEGF) on endothelial cell proliferation, apoptosis and lineage specification during embryonic development. The work provided unexpected evidence that VEGF is involved in the specification of gastrulating mesodermal cells to the endothelial and hematopoietic lineage.